LT3827B - Chimopapaine, pharmaceutical compositions containing thereof, process for purification of chimopapaine, inhibiting peptides and chromatographic carriers - Google Patents

Chimopapaine, pharmaceutical compositions containing thereof, process for purification of chimopapaine, inhibiting peptides and chromatographic carriers Download PDF

Info

Publication number
LT3827B
LT3827B LTIP1645A LTIP1645A LT3827B LT 3827 B LT3827 B LT 3827B LT IP1645 A LTIP1645 A LT IP1645A LT IP1645 A LTIP1645 A LT IP1645A LT 3827 B LT3827 B LT 3827B
Authority
LT
Lithuania
Prior art keywords
solution
chymopalans
phe
chymopamine
added
Prior art date
Application number
LTIP1645A
Other languages
English (en)
Lithuanian (lt)
Inventor
Alan John Barrett
David John Buttle
Daniel Hulbert Rich
Original Assignee
Boots Co Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boots Co Plc filed Critical Boots Co Plc
Publication of LTIP1645A publication Critical patent/LTIP1645A/xx
Publication of LT3827B publication Critical patent/LT3827B/lt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against enzymes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Detergent Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
LTIP1645A 1989-04-28 1993-12-21 Chimopapaine, pharmaceutical compositions containing thereof, process for purification of chimopapaine, inhibiting peptides and chromatographic carriers LT3827B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898909836A GB8909836D0 (en) 1989-04-28 1989-04-28 Therapeutic agent

Publications (2)

Publication Number Publication Date
LTIP1645A LTIP1645A (en) 1995-07-25
LT3827B true LT3827B (en) 1996-03-25

Family

ID=10655944

Family Applications (1)

Application Number Title Priority Date Filing Date
LTIP1645A LT3827B (en) 1989-04-28 1993-12-21 Chimopapaine, pharmaceutical compositions containing thereof, process for purification of chimopapaine, inhibiting peptides and chromatographic carriers

Country Status (34)

Country Link
US (2) US5380656A (enExample)
EP (1) EP0470136B1 (enExample)
JP (1) JPH04506003A (enExample)
KR (1) KR920701241A (enExample)
CN (1) CN1047340A (enExample)
AT (1) ATE107660T1 (enExample)
AU (1) AU631641B2 (enExample)
BG (1) BG60916B1 (enExample)
CA (1) CA2056402C (enExample)
DD (1) DD296960A5 (enExample)
DE (1) DE69010199T2 (enExample)
DK (1) DK0470136T3 (enExample)
EG (1) EG19583A (enExample)
ES (1) ES2055427T3 (enExample)
FI (1) FI914995A7 (enExample)
GB (1) GB8909836D0 (enExample)
GR (1) GR1001011B (enExample)
HR (1) HRP930700A2 (enExample)
HU (2) HUT58345A (enExample)
IE (1) IE64351B1 (enExample)
IL (1) IL94227A (enExample)
IN (2) IN170683B (enExample)
LT (1) LT3827B (enExample)
LV (1) LV10200B (enExample)
MX (1) MX20503A (enExample)
NO (1) NO914206L (enExample)
NZ (1) NZ233475A (enExample)
PL (1) PL166810B1 (enExample)
PT (1) PT93921B (enExample)
RO (1) RO112032B1 (enExample)
RU (1) RU2074891C1 (enExample)
WO (1) WO1990013561A1 (enExample)
YU (1) YU87090A (enExample)
ZA (1) ZA903228B (enExample)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8909836D0 (en) * 1989-04-28 1989-06-14 Boots Co Plc Therapeutic agent
WO1992014696A2 (en) * 1991-02-22 1992-09-03 The Du Pont Merck Pharmaceutical Company SUBSTITUTED α-AMINOALDEHYDES AND DERIVATIVES
CA2061861A1 (en) * 1991-03-04 1992-09-05 Jonathan Duvick Plant polypeptides with inhibitory activity towards pathogenic microorganisms
CN1060519C (zh) * 1991-05-09 2001-01-10 广西亚热带作物研究所 桄榔植物蛋白酶的提取方法
ES2112333T3 (es) * 1991-10-14 1998-04-01 Cash Eng Res Combinacion de control de admision para un sistema compresor.
US6753006B1 (en) 1993-02-22 2004-06-22 American Bioscience, Inc. Paclitaxel-containing formulations
WO1994028012A1 (en) * 1993-05-28 1994-12-08 Warner-Lambert Company Hydroxamate inhibitors of endothelin converting enzyme
CA2360740A1 (en) 1999-03-02 2000-09-08 Boehringer Ingelheim Pharmaceuticals, Inc. Compounds useful as reversible inhibitors of cathepsin s
EA200100972A1 (ru) 1999-03-15 2002-02-28 Аксис Фармасьютикалз, Инк. Новые соединения и композиции как ингибиторы протеаз
US6420364B1 (en) 1999-09-13 2002-07-16 Boehringer Ingelheim Pharmaceuticals, Inc. Compound useful as reversible inhibitors of cysteine proteases
US6703040B2 (en) 2000-01-11 2004-03-09 Intralytix, Inc. Polymer blends as biodegradable matrices for preparing biocomposites
EP1593391B1 (en) 2002-12-25 2013-08-21 Komori, Hiromichi Remedy for degenerative intervertebral discs
US7169405B2 (en) * 2003-08-06 2007-01-30 Warsaw Orthopedic, Inc. Methods and devices for the treatment of intervertebral discs
JP2008505887A (ja) * 2004-07-06 2008-02-28 幾夫 森本 パパイヤ抽出液を含む癌の予防、治療、または改善のための組成物
CN1320111C (zh) * 2004-08-09 2007-06-06 王美岭 一种制备木瓜凝乳酶的方法
US20060241566A1 (en) * 2005-04-11 2006-10-26 Orthox, Llc Nucleus Extraction from Spine Intervertebral Disc
US8642060B2 (en) * 2006-04-24 2014-02-04 Warsaw Orthopedic, Inc. Controlled release systems and methods for osteal growth
US8642059B2 (en) 2006-04-24 2014-02-04 Warsaw Orthopedic, Inc. Controlled release systems and methods for intervertebral discs
US7879027B2 (en) * 2006-04-24 2011-02-01 Warsaw Orthopedic, Inc. Controlled release devices for fusion of osteal structures
US7771414B2 (en) * 2006-04-24 2010-08-10 Warsaw Orthopedic, Inc. Controlled release devices for therapeutic treatments of spinal discs
US20070265633A1 (en) * 2006-05-11 2007-11-15 Moon Jon K Implement and method to extract nucleus from spine intervertebral disc
US8257938B2 (en) * 2009-02-27 2012-09-04 Medical Diagnostic Laboratories, Llc Hemolysin and its protein fragments in sero-detection of Anaplasma phagocytophilum
WO2013038936A1 (ja) * 2011-09-13 2013-03-21 タカラバイオ株式会社 ペルオキシダーゼ反応の停止方法及び反応停止剤
US9375519B2 (en) 2012-06-25 2016-06-28 Surmodics, Inc. Bioerodable poly(etheresteramides) and medical article uses
CN118878631B (zh) * 2024-06-05 2025-04-04 中国海洋大学 一种基于配体垂钓筛选合成牡蛎ace抑制肽的方法

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2098897A (en) 1981-04-13 1982-12-01 Sintokogio Ltd A core making method and apparatus
WO1984000365A1 (en) 1982-07-19 1984-02-02 Nat Res Dev Synthetic peptides and their preparation

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE270723C (enExample) *
US2313875A (en) * 1940-12-17 1943-03-16 Eugene F Jansen Proteolytic enzyme process
US3320131A (en) * 1964-10-23 1967-05-16 Baxter Laboratories Inc Method for the treatment of herniation of intervertebral discs
US3558433A (en) * 1967-11-07 1971-01-26 Baxter Laboratories Inc Process for purification of chymopapain
YU40433B (en) * 1975-02-20 1986-02-28 Lek Tovarna Farmacevtskih Process for obtaining pure, proteolytically active anzymes
US4374926A (en) * 1981-05-13 1983-02-22 Smith Laboratories, Inc. Method for the production of improved chymopapain
US4439423A (en) * 1981-05-13 1984-03-27 Smith Laboratories, Inc. Chymopapain and method for its use
DE3278934D1 (en) * 1981-05-13 1988-09-29 Flint Lab Inc Improved chymopapain and method for its production and use
US4719108A (en) * 1981-05-13 1988-01-12 Smith Laboratories, Inc. Chymopapain composition and method for its use
GB2156821A (en) * 1984-04-03 1985-10-16 Simmons James W Process for purifying chymopapain
HU196624B (en) * 1986-12-08 1988-12-28 Chinoin Gyogyszer Es Vegyeszet Process for producing chymopapain with high specific activity
GB8909836D0 (en) * 1989-04-28 1989-06-14 Boots Co Plc Therapeutic agent

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2098897A (en) 1981-04-13 1982-12-01 Sintokogio Ltd A core making method and apparatus
WO1984000365A1 (en) 1982-07-19 1984-02-02 Nat Res Dev Synthetic peptides and their preparation

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
A L LUACES, A J BARRETT: "Affinity purification and biochemical characterization of histolysin, the major cysteine proteinase of Entamoeba histolytica", BIOCHEMICAL JOURNAL, 1988, pages 903 - 909
D J BUTTLE ET AL.: "Affinity purification of the novel cysteine proteinase papaya proteinase IV, and papain from papaya latex", BIOCHEMICAL JOURNAL, 1989, pages 469 - 476, XP000913659
DUBOIS T. ET AL.: "The thiol proteinases from the latex of Carica papaya L. I. Fractionation, purification and preliminary characterization.", BIOL CHEM HOPPE SEYLER, 1988, pages 733 - 740
LYMAN SMITH, MD: "Enzyme Dissolution of the Nucleus Pulposus in Humans", JAMA, 1964, pages 137 - 140
POLGAR, L.: "Isolation of highly active papaya peptidases A and B from commercial chymopapain", BIOCHIM. BIOPHYS. ACTA, 1981, pages 262 - 269, XP023514995, DOI: doi:10.1016/0005-2744(81)90296-5
RICH, D.H. ET AL.: "Purification of cathepsin B by a new form of affinity chromatography", BIOCHEMICAL JOURNAL, 1986, pages 731 - 734
ZUCKER, S. ET AL.: "Proteolytic activities of papain, chymopapain and papaya proteinase III.", BIOCHIM. BIOPHYS. ACTA, 1985, pages 196 - 204, XP025441048, DOI: doi:10.1016/0167-4838(85)90057-3

Also Published As

Publication number Publication date
NO914206L (no) 1991-12-17
RU2074891C1 (ru) 1997-03-10
AU5547290A (en) 1990-11-29
ATE107660T1 (de) 1994-07-15
ES2055427T3 (es) 1994-08-16
IE901538L (en) 1990-10-28
PL166810B1 (pl) 1995-06-30
FI914995A0 (fi) 1991-10-23
HU211746A9 (en) 1995-12-28
IL94227A0 (en) 1991-01-31
HU903342D0 (en) 1992-01-28
EP0470136B1 (en) 1994-06-22
BG95362A (bg) 1993-12-24
US5380656A (en) 1995-01-10
DE69010199D1 (de) 1994-07-28
LTIP1645A (en) 1995-07-25
ZA903228B (en) 1990-12-28
WO1990013561A1 (en) 1990-11-15
PT93921A (pt) 1990-11-20
PT93921B (pt) 1996-10-31
AU631641B2 (en) 1992-12-03
IN173230B (enExample) 1994-03-12
NO914206D0 (no) 1991-10-25
FI914995A7 (fi) 1991-10-23
DD296960A5 (de) 1991-12-19
GB8909836D0 (en) 1989-06-14
LV10200A (lv) 1994-10-20
CA2056402A1 (en) 1990-10-29
DE69010199T2 (de) 1994-10-13
DK0470136T3 (da) 1994-08-01
CN1047340A (zh) 1990-11-28
HRP930700A2 (en) 1995-06-30
RO112032B1 (ro) 1997-04-30
JPH04506003A (ja) 1992-10-22
GR1001011B (el) 1993-03-31
HUT58345A (en) 1992-02-28
MX20503A (es) 1993-12-01
IL94227A (en) 1994-12-29
BG60916B1 (bg) 1996-06-28
EG19583A (en) 1995-09-30
IN170683B (enExample) 1992-05-02
US5468480A (en) 1995-11-21
KR920701241A (ko) 1992-08-11
CA2056402C (en) 1999-11-16
YU87090A (sh) 1992-09-07
GR900100315A (en) 1991-09-27
EP0470136A1 (en) 1992-02-12
LV10200B (en) 1995-04-20
IE64351B1 (en) 1995-07-26
NZ233475A (en) 1991-10-25

Similar Documents

Publication Publication Date Title
RU2074891C1 (ru) Способ доочистки химопапаина
JP3701028B2 (ja) 高純度フォンビルブラント因子の入手方法
JPH0764875B2 (ja) 血液凝固阻害作用を有する新規ポリペプチド
US20040063187A1 (en) Process for the preparation in pure form of the protease activating blood clotting factor VII, its proenzyme or a mixture of both proteins by means of chromatography
JPS6322027A (ja) セリンプロテア−ゼ阻害剤
CA2006684C (en) Monoclonal antibody against protein c
CA2366678A1 (en) Synthetic complementary peptides and ophthalmologic uses thereof
JP4250769B2 (ja) 高度に精製されたｖＷＦまたは因子ＶＩＩＩ／ｖＷＦ複合体を得る方法
JPH01149799A (ja) Ｌｙｓ―Ａｒｇ―Ａｓｐ配列を含むテトラおよびペンタペプチド、およびそれらの医薬物、とくに抗トロンビン剤、としての使用
US5190919A (en) Antihemostatic factor vii peptides
JP2660514B2 (ja) 抗血液凝固作用を有するポリペプチド
JP2003501012A (ja) ボツリヌス菌毒素ｂ及び破傷風菌神経毒素の特異的阻害剤及び治療薬としてのプレビン類
EP0639202B1 (en) Stable polypeptide composition
CA2154231C (fr) Procede de preparation d'un concentre d'inhibiteur de la c1-esterase (c1-inh), et concentre obtenu, a usage therapeutique
WO2004098628A2 (en) Synthetic peptide analogs of arg-pro-pro-gly-phe as selective inhibitors of thrombin and thrombin activation of protease activated receptors 1 and 4
US5837686A (en) Peptides and antibodies for treatment of rheumatoid arthritis
JPH01221396A (ja) ８因子の精製に使用するペプチド
AU781741B2 (en) Process for the preparation in pure form of the protease activating blood clotting factor VII, its proenzyme or mixture of both proteins by means of ion-exchange chromatography

Legal Events

Date Code Title Description
MM9A Lapsed patents

Effective date: 20021221